CareClix Holdings, Inc. (SOLI) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
1709 N. HARBOR CITY BOULEVARD MELBOURNE, FL 32935 |
| State of Incorp. | FL |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 136 | 385 | 7 | |||
| Cash and cash equivalents | 136 | 385 | 7 | |||
| Receivables | 240 | 280 | ||||
| Inventory, net of allowances, customer advances and progress billings | 37 | 39 | 40 | |||
| Inventory | 37 | 39 | 40 | |||
| Prepaid expense | ||||||
| Total current assets: | 412 | 704 | 47 | |||
| Noncurrent Assets | ||||||
| Property, plant and equipment | 73 | 77 | 8 | |||
| Intangible assets, net (including goodwill) | 1,736 | 1,786 | ||||
| Goodwill | 50 | |||||
| Intangible assets, net (excluding goodwill) | 1,736 | 1,736 | ||||
| Total noncurrent assets: | 1,809 | 1,862 | 8 | |||
| TOTAL ASSETS: | 2,221 | 2,567 | 55 | |||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities | 227 | 120 | 6 | |||
| Interest and dividends payable | 67 | 22 | ||||
| Employee-related liabilities | ||||||
| Accounts payable | 68 | 9 | 6 | |||
| Accrued liabilities | 92 | 89 | ||||
| Deferred revenue | ||||||
| Debt | 1,680 | 1,680 | ||||
| Deferred compensation liability | 25 | |||||
| Derivative instruments and hedges, liabilities | ||||||
| Due to related parties | 372 | 372 | 373 | |||
| Other undisclosed current liabilities | 4,107 | 4,027 | 1,368 | |||
| Total current liabilities: | 6,411 | 6,199 | 1,747 | |||
| Noncurrent Liabilities | ||||||
| Liabilities, other than long-term debt | ||||||
| Deferred income tax liabilities | ||||||
| Total noncurrent liabilities: | ||||||
| Total liabilities: | 6,411 | 6,199 | 1,747 | |||
| Equity | ||||||
| Equity, attributable to parent | (4,190) | (3,633) | (1,692) | |||
| Common stock | 104 | 104 | 116 | |||
| Additional paid in capital | 103 | 103 | 90 | |||
| Accumulated deficit | (4,396) | (3,839) | (1,899) | |||
| Total equity: | (4,190) | (3,633) | (1,692) | |||
| TOTAL LIABILITIES AND EQUITY: | 2,221 | 2,567 | 55 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | ||
|---|---|---|---|---|---|
| Revenues | 532 | 439 | 4 | ||
| Cost of revenue | (349) | (286) | (3) | ||
| Gross profit: | 182 | 153 | 2 | ||
| Operating expenses | (690) | (391) | (125) | ||
| Operating loss: | (508) | (238) | (123) | ||
| Nonoperating expense | (49) | (1,703) | |||
| Other nonoperating expense | (1,703) | ||||
| Interest and debt expense | (49) | (25) | (3) | ||
| Loss from continuing operations before equity method investments, income taxes: | (606) | (1,965) | (127) | ||
| Other undisclosed income from continuing operations before income taxes | |||||
| Loss from continuing operations before income taxes: | (606) | (1,965) | (127) | ||
| Other undisclosed loss from continuing operations | |||||
| Loss from continuing operations: | (606) | (1,965) | (127) | ||
| Loss before gain (loss) on sale of properties: | (606) | (1,965) | (127) | ||
| Net loss: | (606) | (1,965) | (127) | ||
| Other undisclosed net income (loss) attributable to parent | 49 | 25 | |||
| Net loss available to common stockholders, diluted: | (557) | (1,940) | (127) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | ||
|---|---|---|---|---|---|
| Net loss: | (606) | (1,965) | (127) | ||
| Comprehensive loss, net of tax, attributable to parent: | (606) | (1,965) | (127) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.